ROFLUMILAST
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69292-630 -
Package NDC
69292-630-10 -
Package NDC
69292-630-14 -
Package NDC
69292-630-20 -
Package NDC
69292-630-28 -
Application number
ANDA208236 -
SPL ID
0dcd9104-401e-4675-9166-939f0d3aae4b -
SPL set ID
cb3781ff-5350-4f9a-b247-0b04eb0f2b92 -
UNII
0P6C6ZOP5U -
RxCUI
1091839 -
RxCUI
2001319
What the source publishes
- Labeler
- Amici Pharma Inc.
- Active ingredients
- ROFLUMILAST
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "ROFLUMILAST",
"splId": "0dcd9104-401e-4675-9166-939f0d3aae4b",
"labels": [
{
"setId": "cb3781ff-5350-4f9a-b247-0b04eb0f2b92",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb3781ff-5350-4f9a-b247-0b04eb0f2b92",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb3781ff-5350-4f9a-b247-0b04eb0f2b92"
}
],
"routes": [
"ORAL"
],
"labeler": "Amici Pharma Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (69292-630-10) / 10 TABLET in 1 BLISTER PACK",
"package_ndc": "69292-630-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20260205"
},
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (69292-630-14) / 14 TABLET in 1 BLISTER PACK",
"package_ndc": "69292-630-14",
"identifierStatus": "well-formed",
"marketing_start_date": "20260205"
},
{
"sample": false,
"description": "2 BLISTER PACK in 1 CARTON (69292-630-20) / 10 TABLET in 1 BLISTER PACK",
"package_ndc": "69292-630-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20260205"
},
{
"sample": false,
"description": "2 BLISTER PACK in 1 CARTON (69292-630-28) / 14 TABLET in 1 BLISTER PACK",
"package_ndc": "69292-630-28",
"identifierStatus": "well-formed",
"marketing_start_date": "20260205"
}
],
"productId": "69292-630_0dcd9104-401e-4675-9166-939f0d3aae4b",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "69292-630",
"deaSchedule": null,
"genericName": "ROFLUMILAST",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ROFLUMILAST",
"strength": "250 ug/1"
}
],
"applicationNumber": "ANDA208236",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260205",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000182961",
"N0000182960"
],
"unii": [
"0P6C6ZOP5U"
],
"rxcui": [
"1091839",
"2001319"
],
"spl_set_id": [
"cb3781ff-5350-4f9a-b247-0b04eb0f2b92"
],
"pharm_class_epc": [
"Phosphodiesterase 4 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Phosphodiesterase 4 Inhibitors [MoA]"
],
"manufacturer_name": [
"Amici Pharma Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69292-630_0dcd9104-401e-4675-9166-939f0d3aae4b"